With this in mind, a better understanding of the mechanisms that regulate acute hepatic NF-κB activation in the IUGR neonate could provide potential therapeutical approaches to prevent morbidity and mortality associated with in utero growth restriction. This evidence concerns the gene NFKB1 and fetal growth restriction.